Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a highly prevalent, severe, and dose-limiting toxicity of several chemotherapy regimens for the treatment of multiple cancers including lung, breast, prostate, gastrointestinal, blood, and others. Patients with CIPN may experience numbness, tingling, pain, and cramping in the hands and feet, as well as problems with balance and gait that increase the risk of falls, reduce physical function, and hinder activities of daily living. At this point there are extremely limited treatment options for CIPN. Fortunately, a growing body of preliminary evidence suggests that exercise, physical therapy, and occupational therapy may help prevent, treat, and manage CIPN. Although there is not definitive evidence for the benefits of exercise on CIPN due to lack of Phase III randomized controlled trials, exercise is generally helpful in the cancer treatment continuum and poses low risk for patients with the help of a qualified professional. Therefore, we present clinical suggestions in the use of exercise for CIPN, including assessments of patient risk factors and other considerations. We conclude with an example exercise prescription that a qualified exercise professional can adapt for the specific needs, risks, and abilities of each individual patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR et al (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470. https://doi.org/10.1016/j.pain.2014.09.020
Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ et al (2019) Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview. Support Care Cancer:1–9. https://pubmed.ncbi.nlm.nih.gov/31363906/
Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781. https://doi.org/10.1002/ana.24951
Gu Y, Menzies AM, Long GV, Fernando S, Herkes G (2017) Immune mediated neuropathy following checkpoint immunotherapy. J Clin Neurosci 45:14–17
Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A et al (2012) Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: north central Cancer treatment group trial N08C1. Cancer 118(20):5171–5178
Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M et al (2013) Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. Cancer 119(2):438–444
Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE et al (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33(30):3416
Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM et al (2018) Two-year trends of Taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L- carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669–676. https://doi.org/10.1093/jnci/djx259
Bandos H, Melnikow J, Rivera DR, Swain SM, Sturtz K, Fehrenbacher L et al (2018) Long-term peripheral neuropathy in breast cancer patients treated with adjuvant chemotherapy: NRG oncology/NSABP B-30. J Natl Canc Inst 110(2):djx162. https://doi.org/10.1093/jnci/djx162
daCosta DBM, Copher R, Basurto E, Faria C, Lorenzo R (2014) Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer. Am Health Drug Benefits 7(7):386–396
Lyman GH (2009) Impact of chemotherapy dose intensity on cancer patient outcomes. Journal of the National Comprehensive Cancer Network : JNCCN 7(1):99–108
Gewandter JS, Kleckner AS, Marshall JH, Brown JS, Curtis LH, Bautista J et al (2019) Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data. Support Care Cancer:1–10. https://pubmed.ncbi.nlm.nih.gov/31494735/
Pike CT, Birnbaum HG, Muehlenbein CE, Pohl GM, Natale RB (2012) Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancer. Chemother Res Pract 2012:913848. https://doi.org/10.1155/2012/913848
Chan CW, Cheng H, Au SK, Leung KT, Li YC, Wong KH et al (2018) Living with chemotherapy- induced peripheral neuropathy: uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors. Eur J Oncol Nurs 36:135–141
Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ et al (2017) Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients. Breast Cancer Res Treat 164(1):69–77. https://doi.org/10.1007/s10549-017-4230-8
Wasilewski A, Mohile N (2020) Meet the expert: how I treat chemotherapy-induced peripheral neuropathy. J Geriatr Oncol. https://doi.org/10.1016/j.jgo.2020.06.008
Kolb NA, Smith AG, Singleton JR, Beck SL, Stoddard GJ, Brown S et al (2016) The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the risk of falling. JAMA Neurol 73(7):860–866. https://doi.org/10.1001/jamaneurol.2016.0383
Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C et al (2013) Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Supportive Care Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 21(7):2059–2066. https://doi.org/10.1007/s00520-013-1766-y
Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL et al (2020) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol 38(28):3325–3348. https://doi.org/10.1200/JCO.20.01399
Brami C, Bao T, Deng G (2016) Natural products and complementary therapies for chemotherapy- induced peripheral neuropathy: a systematic review. Crit Rev Oncol Hematol 98:325–334. https://doi.org/10.1016/j.critrevonc.2015.11.014
Dorsey SG, Kleckner IR, Barton D, Mustian K, O'Mara A, St Germain D et al (2019) NCI clinical trials planning meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djz011
Duregon F, Vendramin B, Bullo V, Gobbo S, Cugusi L, Di Blasio A et al (2018) Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review. Crit Rev Oncol Hematol 121:90–100. https://doi.org/10.1016/j.critrevonc.2017.11.002
Kanzawa-Lee GA, Larson JL, Resnicow K, Smith EML (2020) Exercise effects on chemotherapy- induced peripheral neuropathy: a comprehensive integrative review. Cancer Nurs 43(3):E172–EE85
Kleckner IR, Park SB, Streckmann F, Wiskemann J, Hardy S, Mohile NA (2021) Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy. In: Lustberg MB, Loprinzi CL (eds) Diagnosis, management and emerging strategies for chemotherapy induced neuropathy. Springer, Berlin
Campbell KL, Weller S, Cormie P, Lane KN, Rauw JM, Goulart J (2020) Enhancing safety of exercise for individuals with bone metastases: screening recommendations developed through Delphi consensus process. Am Soc Clin Oncol. https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e24042
Campbell KL, Neil SE, Winters-Stone KM (2012) Review of exercise studies in breast cancer survivors: attention to principles of exercise training. Br J Sports Med 46(13):909–916
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS et al (2019) Exercise guidelines for Cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc 51(11):2375–2390. https://doi.org/10.1249/MSS.0000000000002116
Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C et al (2018) Exercise for toxicity management in cancer—a narrative review. Oncology & hematology review 14(1):28
Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG et al (2012) Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Support Care Cancer 20(10):2433–2439
Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V et al (2012) Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer 118(S8):2207–2216
Caspersen CJ, Powell KE, Christenson GM (1985) Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100(2):126–131
Wasfy MM, Baggish AL (2016) Exercise dose in clinical practice. Circulation 133(23):2297–2313
Neil-Sztramko SE, Medysky ME, Campbell KL, Bland KA, Winters-Stone KM (2019) Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review. BMC Cancer 19(1):321
Kenjale AA, Hornsby WE, Crowgey T, Thomas S, Herndon JE (2014) Pre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients. Oncologist 19(9):999
American College of Sports Medicine (2017) ACSM’s guidelines for exercise testing and prescription. Lippincott, Williams, & Wilkins, Baltimore, MD
Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF (2018) The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Rep 3(2):1–19
Wolin KY, Schwartz AL, Matthews CE, Courneya KS, Schmitz KH (2012) Implementing the exercise guidelines for cancer survivors. J Support Oncol 10(5):171
Streckmann F, Balke M (2018) Bewegungstherapie bei Polyneuropathie. DGNeurologie 1(1):47–57
Carayol M, Bernard P, Boiche J, Riou F, Mercier B, Cousson-Gélie F et al (2013) Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol 24(2):291–300
Boutcher SH (1993) Emotion and aerobic exercise. In: Singer RN, Murphey M, Tennant LK (eds) Handbook of research on sport psychology. Macmillan, New York, pp 799–814
Worthen-Chaudhari L, Lamantia MT, Monfort SM, Mysiw W, Chaudhari AMW, Lustberg MB (2019) Partnered, adapted argentine tango dance for cancer survivors: a feasibility study and pilot study of efficacy. Clin Biomech (Bristol, Avon) 70:257–264. https://doi.org/10.1016/j.clinbiomech.2019.08.010
Schwenk M, Grewal GS, Holloway D, Muchna A, Garland L, Najafi B (2016) Interactive sensor- based balance training in older Cancer patients with chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Gerontology 62(5):553–563. https://doi.org/10.1159/000442253
Acknowledgements
The authors acknowledge the following funding mechanisms to support this work, including the National Cancer Institute K07CA221931 to IRK, a National Health and Medical Research Council of Australia Career Development Fellowship (#1148595) to SBP. The authors also thank the Transdisciplinary Research in Energetics and Cancer (TREC) Training Workshop funded by the National Cancer Institute (R25CA203650) and the Multinational Association for Supportive Care in Cancer (MASCC) for facilitating collaboration among the authors. The authors also thank Dr. Amber Kleckner for editorial input.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kleckner, I.R., Park, S.B., Streckmann, F., Wiskemann, J., Hardy, S., Mohile, N. (2021). Clinical and Practical Recommendations in the Use of Exercise, Physical Therapy, and Occupational Therapy for Chemotherapy-Induced Peripheral Neuropathy. In: Lustberg, M., Loprinzi, C. (eds) Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy. Springer, Cham. https://doi.org/10.1007/978-3-030-78663-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-78663-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-78662-5
Online ISBN: 978-3-030-78663-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)